Another noteworthy finding in this study is that even in Western countries, a subset of overweight and even obese subjects with NAFLD were relatively insulin sensitive, i.e., with a fasting insulin < 12 μU/mL and [glucose] < 100 mg/dL. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.